Dashboard
Manage Tickers

TGTXTG THERAPEUTICS, INC.

Nasdaq tgtherapeutics.com


$ 17.03 $ -0.01 (-0.06 %)    

Friday, 10-May-2024 10:20:10 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.02 $ -0.86 (-0.19 %)
DIA $ 395.38 $ 0.12 (0.03 %)
SPY $ 521.21 $ -0.31 (-0.06 %)
TLT $ 90.19 $ -0.12 (-0.13 %)
GLD $ 218.84 $ -0.92 (-0.42 %)
$ 16.92
$ 17.04
$ 15.95 x 300
$ 16.99 x 200
$ 16.94 - $ 17.10
$ 6.46 - $ 35.22
2,679,217
na
2.61B
$ 2.09
$ 63.47
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-02-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 05-10-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-15-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-16-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-tg-therapeutics-raises-price-target-to-49
HC Wainwright & Co. Maintains Buy on TG Th...
05/02/2024 17:28:20

HC Wainwright & Co. analyst Edward White maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target ...

ladenburg-thalmann-maintains-buy-on-tg-therapeutics-raises-price-target-to-40
Ladenburg Thalmann Maintains Buy on TG The...
05/02/2024 13:04:30

Ladenburg Thalmann analyst Matthew Kaplan maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target fro...

why-amd-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why AMD Shares Are Trading Lower By Around...
05/01/2024 17:01:56

powell-industries-posts-upbeat-results-joins-a10-networks-garmin-dupont-and-other-big-stocks-moving-higher-on-wednesday
Powell Industries Posts Upbeat Results, Jo...
05/01/2024 14:27:48

watching-tg-therapeutics-hearing-ma-blog-says-strong-sales-forecast-for-multiple-sclerosis-drug-that-may-draw-suitors
Watching TG Therapeutics; Hearing M&A Blog...
05/01/2024 14:03:19

Core News & Articles
Market-Moving News for May 1 st
05/01/2024 12:44:43

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

Core News & Articles
Market-Moving News for May 1st
05/01/2024 12:41:28

TGTX: 31% | TG Therapeutics shares are trading higher following a Q1 revenue beat and increased 2024 Briumvi US net product rev...

tg-therapeutics-updates-2024-briumvi-us-net-product-revenue-target-to-approximately-270m-290m-versus-prior-guidance-of-220m-260m
TG Therapeutics Updates 2024 Briumvi U.S. ...
05/01/2024 11:10:02

tg-therapeutics-targets-q2-2024-briumvi-us-net-product-revenue-of-approximately-65m
TG Therapeutics Targets Q2 2024 Briumvi U....
05/01/2024 11:09:36

tg-therapeutics-q1-2024-gaap-eps-007-misses-004-estimate-sales-63474m-beat-54579m-estimate
TG Therapeutics Q1 2024 GAAP EPS $(0.07) M...
05/01/2024 11:02:28

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0...

hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on TG T...
04/18/2024 17:59:44

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...

jp-morgan-reiterates-overweight-on-tg-therapeutics-maintains-25-price-target
JP Morgan Reiterates Overweight on TG Ther...
04/18/2024 17:30:57

JP Morgan analyst Eric Joseph reiterates TG Therapeutics (NASDAQ:TGTX) with a Overweight and maintains $25 price target.

ladenburg-thalmann-reiterates-buy-on-tg-therapeutics-maintains-39-price-target
Ladenburg Thalmann Reiterates Buy on TG Th...
04/18/2024 17:27:41

Ladenburg Thalmann analyst Matthew Kaplan reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $39 price target.

tg-therapeutics-receives-national-contract-with-the-department-of-veterans-affairs-for-briumvi-ublituximab-to-be-the-preferred-agent-listed-on-va-national-formulary-for-anti-cd20-antibody-indications-for-relapsing-forms-of-multiple-sclerosis
TG Therapeutics Receives National Contract...
04/18/2024 11:44:56

tg-therapeutics-announced-two-additional-data-presentations-from-ultimate-i-and-ii-phase-3-trials-evaluating-briumvi-ublituximab-for-relapsing-forms-of-multiple-sclerosis-at-the-2024-american-academy-of-neurology-annual-meeting
TG Therapeutics Announced Two Additional D...
04/18/2024 11:40:19

tg-therapeutics-inc-awarded-186776520-contract-from-department-of-veterans-affairs-nac-pharmaceuticals-for-pharmaceutical-preparation-manufacturing-6505--anti-cd20-antibodies
TG Therapeutics Inc Awarded $186,776,520 C...
04/17/2024 18:15:27

https://sam.gov/opp/5efea17b278941f7ae9ba627116a29be/view 

tgtx---analyzing-tg-therapeuticss-short-interest
(TGTX) - Analyzing TG Therapeutics's Short...
03/13/2024 19:00:25

tg-therapeutics-announces-schedule-of-data-presentations-for-briumvi-ublituximab-in-multiple-sclerosis-at-american-academy-of-neurology-2024-annual-meeting
TG Therapeutics Announces Schedule Of Data...
03/08/2024 12:37:37

hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on TG T...
03/01/2024 19:22:04

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $45 price tar...

tg-therapeutics-announced-data-presentation-from-ultimate-i--ii-phase-3-trials-and-enhance-phase-3b-trial-evaluating-briumvi-for-relapsing-forms-of-multiple-sclerosis-at-americas-committee-for-treatment-and-research-in-multiple-sclerosis-annual-forum
TG Therapeutics Announced Data Presentatio...
03/01/2024 12:35:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION